Compare McKesson Corporation (MCK) vs Spotify Technology (SPOT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
McKesson Corporation vs Spotify Technology — how do they compare? McKesson Corporation trades at $828.24 (market cap $97.35B), while Spotify Technology trades at $494 (market cap $101.23B). The key difference: McKesson Corporation and Spotify Technology are close in size by market cap, and McKesson Corporation pays a 0.39% dividend while Spotify Technology pays none. Which is the better fit depends on your goals.
| MCK | SPOT | |
|---|---|---|
Market Cap | $97.35B | $101.23B |
Sector | Health | Media |
52-Week High | $995.69 | $738.53 |
52-Week Low | $659.01 | $412.75 |
Enterprise Value | $101.98B | $91.81B |
Dividend Yield | 0.39% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
McKesson Corporation (MCK) trades at $831.60, down 1.16% on the day, with a bullish technical signal and positive earnings momentum after beating estimates for three consecutive quarters. The stock shows strong analyst support with an 80% buy rating and a consensus price target of $932.83, implying potential upside. Revenue growth is robust, reaching $359.05 billion in 2025, though net margins remain thin at 1.18%. Cash flow from operations improved to $6.09 billion in 2025, supporting financial stability.
The outlook for MCK is positive, driven by earnings beats, analyst optimism, and solid cash generation. Key opportunities include growth in specialty pharma and oncology services. Risks involve policy uncertainties, competitive pressures, and execution challenges. The stock's current price near key support at $829 suggests a critical level for near-term direction.
Spotify (SPOT) trades at $493.49, up 3.21% today, showing strong momentum after recent earnings beats. The stock faces technical resistance near $498 with bearish moving average signals. Fundamentally, the company demonstrates impressive growth with revenue reaching $17.19B in 2025 and net income surging to $2.21B, representing a 12.87% margin. Recent AI integration initiatives and expanded family account features highlight ongoing innovation.
Wall Street maintains a bullish stance with 61.5% buy ratings and a $617 consensus target, representing 25% upside potential. However, elevated valuation multiples (P/E 32.6, P/S 5.0) and competitive pressures from streaming rivals present near-term risks. The Q2 2026 earnings report will be crucial for validating the current growth trajectory.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →About Spotify Technology
Spotify Technology S.A. provides music streaming services. The Company offers commercial-free music and ad-supported services to subscribers. Spotify Technology serves clients worldwide.
Read more on SPOT →
